Literature DB >> 2045219

Synthesis of novel immunologically active tripalmitoyl-S-glycerylcysteinyl lipopeptides as useful intermediates for immunogen preparations.

J Metzger1, K H Wiesmüller, R Schaude, W G Bessler, G Jung.   

Abstract

The synthesis and characterization of lipopeptides consisting of the lipoamino acid N-palmitoyl-S-[2,3-bis(palmitoyloxy)-(2RS)-propyl]-[R]-cysteine (Pam3Cys-OH) and different peptide segments and/or spacer molecules is described. Pam3Cys-peptides, which are derived from the immunologically active N-terminus of bacterial lipoprotein, were obtained either by solution or solid phase peptide synthesis. In particular, the amphiphilic and water-soluble lipohexapeptides Pam3Cys-Ser-(Lys)4 and Pam3Cys-Ser-(Glu)4 proved to be potent macrophage and B-cell activators and non-toxic, non-pyrogenic immune adjuvants in combination with or covalently linked to antigens and haptens.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2045219     DOI: 10.1111/j.1399-3011.1991.tb00732.x

Source DB:  PubMed          Journal:  Int J Pept Protein Res        ISSN: 0367-8377


  9 in total

1.  Lipopeptides are effective stimulators of tyrosine phosphorylation in human myeloid cells.

Authors:  S Offermanns; R Seifert; J W Metzger; G Jung; A Lieberknecht; U Schmidt; G Schultz
Journal:  Biochem J       Date:  1992-03-01       Impact factor: 3.857

2.  [Lipopeptides as natural adjuvants for vaccines from Gram-negative bacteria].

Authors:  S Schlecht; K H Wiesmüller; G Jung; W G Bessler
Journal:  Naturwissenschaften       Date:  1993-01

3.  Responsiveness of cardiac Na+ channels to a site-directed antiserum against the cytosolic linker between domains III and IV and their sensitivity to other modifying agents.

Authors:  W Beck; I Benz; W Bessler; G Jung; M Kohlhardt
Journal:  J Membr Biol       Date:  1993-06       Impact factor: 1.843

4.  Structure-activity relationships in toll-like receptor-2 agonistic diacylthioglycerol lipopeptides.

Authors:  Wenyan Wu; Rongti Li; Subbalakshmi S Malladi; Hemamali J Warshakoon; Matthew R Kimbrell; Michael W Amolins; Rehman Ukani; Apurba Datta; Sunil A David
Journal:  J Med Chem       Date:  2010-04-22       Impact factor: 7.446

5.  Next-Generation Diprovocims with Potent Human and Murine TLR1/TLR2 Agonist Activity That Activate the Innate and Adaptive Immune Response.

Authors:  Ming-Hsiu Yang; Jamie L Russell; Yuto Mifune; Ying Wang; Hexin Shi; Eva Marie Y Moresco; Daniel J Siegwart; Bruce Beutler; Dale L Boger
Journal:  J Med Chem       Date:  2022-06-29       Impact factor: 8.039

6.  Diprovocims: A New and Exceptionally Potent Class of Toll-like Receptor Agonists.

Authors:  Matthew D Morin; Ying Wang; Brian T Jones; Yuto Mifune; Lijing Su; Hexin Shi; Eva Marie Y Moresco; Hong Zhang; Bruce Beutler; Dale L Boger
Journal:  J Am Chem Soc       Date:  2018-10-16       Impact factor: 15.419

7.  Covalent attachment of functionalized lipid bilayers to planar waveguides for measuring protein binding to biomimetic membranes.

Authors:  S Heyse; H Vogel; M Sänger; H Sigrist
Journal:  Protein Sci       Date:  1995-12       Impact factor: 6.725

8.  Synergistic stimulation of human B lymphocytes by anti-CD40 monoclonal antibodies and synthetic lipopeptide analogues from Escherichia coli lipoprotein.

Authors:  M Edinger; W G Bessler; B Kleine
Journal:  Immunology       Date:  1994-02       Impact factor: 7.397

9.  Fine mapping of HIV-1 Nef-epitopes by monoclonal antibodies.

Authors:  H Siakkou; S Jahn; N Kienzle; R Ulrich; C Grötzinger; T Schneider; B Kohleisen; G Pauli; R Spohn; G Jung
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.